Turning Cancer’s Double Agents Against It: How Reprogramming Tumor-Associated Macrophages Could Supercharge Immunotherapy
Researchers are uncovering how certain immune cells meant to protect us can instead help tumors evade attack. By reprogramming these tumor-associated macrophages back into cancer-fighting allies, scientists hope to boost the power and durability of modern immunotherapies.